$53.11
-0.05-0.09%
Última actualización: Nov 24, 5:44 PM
Comments
Loading...
Calificaciones de analistas, precios objetivo, pronóstico
HF Sinclair Corp tiene un precio objetivo de consenso de $59.54 basado en las calificaciones de 14 analistas. El máximo es $78, emitido por B of A Securities el marzo 15, 2024. El mínimo es $38, emitido por Wells Fargo el junio 11, 2025. Las 3 calificaciones de analistas más recientes fueron publicadas por Piper Sandler, Mizuho y UBS el noviembre 14, 2025, noviembre 6, 2025 y noviembre 4, 2025, respectivamente. Con un precio objetivo promedio de $63.67 entre Piper Sandler, Mizuho y UBS, hay una 20.81% upside implícita para HF Sinclair Corp según estas calificaciones más recientes de analistas.
Firmas de analistas que realizan recomendaciones1
Piper Sandler
Mizuho
UBS
Raymond James
Wells Fargo
1calculado a partir de las calificaciones de los analistas
Calificaciones de analistas para HF Sinclair
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/14/2025 | 21.44% | Piper Sandler | $59 → $64 | Maintains | Neutral | |||
11/06/2025 | 17.65% | Mizuho | $60 → $62 | Maintains | Outperform | |||
11/04/2025 | 23.34% | UBS | $63 → $65 | Maintains | Buy | |||
10/17/2025 | 23.34% | Raymond James | $60 → $65 | Reiterates | Strong Buy → Strong Buy | |||
10/17/2025 | 10.06% | Wells Fargo | → $58 | Initiates | → Equal-Weight | |||
10/09/2025 | 25.24% | Scotiabank | $61 → $66 | Maintains | Sector Outperform | |||
10/03/2025 | 13.85% | Morgan Stanley | $50 → $60 | Maintains | Overweight | |||
10/02/2025 | 19.54% | UBS | $58 → $63 | Maintains | Buy | |||
10/01/2025 | 2.47% | Barclays | $45 → $54 | Maintains | Equal-Weight | |||
09/18/2025 | 15.75% | Goldman Sachs | $54 → $61 | Maintains | Buy | |||
09/15/2025 | 13.85% | Mizuho | $52 → $60 | Maintains | Outperform | |||
09/11/2025 | 11.95% | Piper Sandler | $51 → $59 | Maintains | Neutral | |||
09/09/2025 | 13.85% | Raymond James | $57 → $60 | Maintains | Strong Buy | |||
08/26/2025 | 10.06% | UBS | $51 → $58 | Maintains | Buy | |||
08/08/2025 | -1.33% | Mizuho | $50 → $52 | Maintains | Outperform | |||
08/04/2025 | -3.23% | UBS | $48 → $51 | Maintains | Buy | |||
07/22/2025 | -3.23% | Piper Sandler | $53 → $51 | Downgrade | Overweight → Neutral | |||
07/16/2025 | -5.12% | Morgan Stanley | $44 → $50 | Maintains | Overweight | |||
07/15/2025 | 0.57% | Piper Sandler | $43 → $53 | Maintains | Overweight | |||
07/14/2025 | — | Wolfe Research | — | Downgrade | Peer Perform → Underperform | |||
07/11/2025 | 15.75% | Scotiabank | $49 → $61 | Maintains | Sector Outperform | |||
07/09/2025 | -18.41% | Barclays | $32 → $43 | Maintains | Equal-Weight | |||
06/11/2025 | -27.89% | Wells Fargo | $34 → $38 | Maintains | Equal-Weight | |||
05/13/2025 | -10.82% | Mizuho | $40 → $47 | Upgrade | Neutral → Outperform | |||
05/12/2025 | -39.28% | Barclays | $29 → $32 | Maintains | Equal-Weight | |||
05/02/2025 | -35.48% | Wells Fargo | $44 → $34 | Maintains | Equal-Weight | |||
05/02/2025 | -24.1% | Piper Sandler | $46 → $40 | Maintains | Overweight | |||
04/24/2025 | -16.51% | Morgan Stanley | $50 → $44 | Maintains | Overweight | |||
04/16/2025 | -44.97% | Barclays | $35 → $29 | Maintains | Equal-Weight | |||
04/11/2025 | -7.02% | Scotiabank | $51 → $49 | Maintains | Sector Outperform | |||
04/03/2025 | -24.1% | Mizuho | $45 → $40 | Maintains | Neutral | |||
03/21/2025 | -16.51% | Wells Fargo | $42 → $44 | Maintains | Equal-Weight | |||
03/14/2025 | -33.59% | Barclays | $37 → $35 | Maintains | Equal-Weight | |||
03/14/2025 | -5.12% | Morgan Stanley | $51 → $50 | Maintains | Overweight | |||
03/07/2025 | — | Piper Sandler | — | Maintains | Overweight | |||
01/13/2025 | -29.79% | Barclays | $42 → $37 | Maintains | Equal-Weight | |||
12/16/2024 | -14.61% | Mizuho | $50 → $45 | Maintains | Neutral | |||
12/10/2024 | -5.12% | JP Morgan | $51 → $50 | Maintains | Neutral | |||
12/09/2024 | -14.61% | Wells Fargo | $53 → $45 | Downgrade | Overweight → Equal-Weight | |||
11/11/2024 | -20.3% | Barclays | $44 → $42 | Maintains | Equal-Weight | |||
11/04/2024 | 4.36% | UBS | $58 → $55 | Maintains | Buy | |||
10/10/2024 | 8.16% | Scotiabank | $66 → $57 | Maintains | Sector Outperform | |||
10/10/2024 | -5.12% | Mizuho | $53 → $50 | Maintains | Neutral | |||
10/09/2024 | 0.57% | Wells Fargo | $54 → $53 | Maintains | Overweight | |||
10/07/2024 | -16.51% | Barclays | $53 → $44 | Maintains | Equal-Weight | |||
10/04/2024 | 0.57% | BMO Capital | $57 → $53 | Maintains | Outperform | |||
10/02/2024 | -3.23% | JP Morgan | $60 → $51 | Maintains | Neutral | |||
09/20/2024 | -7.02% | Piper Sandler | $58 → $49 | Maintains | Overweight | |||
09/16/2024 | 8.16% | Morgan Stanley | $63 → $57 | Maintains | Overweight | |||
09/16/2024 | 0.57% | Mizuho | $55 → $53 | Maintains | Neutral | |||
09/03/2024 | 2.47% | Wells Fargo | $60 → $54 | Maintains | Overweight | |||
08/19/2024 | 13.85% | JP Morgan | $59 → $60 | Maintains | Neutral | |||
08/13/2024 | 32.83% | UBS | $73 → $70 | Maintains | Buy | |||
08/05/2024 | 0.57% | Barclays | $51 → $53 | Maintains | Equal-Weight | |||
08/02/2024 | 13.85% | Wells Fargo | $61 → $60 | Maintains | Overweight | |||
07/18/2024 | — | Wolfe Research | — | Reinstates | → Peer Perform | |||
07/12/2024 | 15.75% | Wells Fargo | $75 → $61 | Maintains | Overweight | |||
07/10/2024 | -3.23% | Barclays | $56 → $51 | Maintains | Equal-Weight | |||
07/02/2024 | 11.95% | JP Morgan | $61 → $59 | Maintains | Neutral | |||
07/01/2024 | 6.26% | Barclays | $60 → $56 | Maintains | Equal-Weight | |||
06/20/2024 | 15.75% | Mizuho | $64 → $61 | Maintains | Neutral | |||
06/14/2024 | 10.06% | Piper Sandler | $65 → $58 | Maintains | Overweight | |||
06/06/2024 | 42.31% | Wells Fargo | $76 → $75 | Maintains | Overweight | |||
05/14/2024 | 23.34% | Piper Sandler | $70 → $65 | Maintains | Overweight | |||
05/13/2024 | 21.44% | Mizuho | $65 → $64 | Maintains | Neutral | |||
04/15/2024 | 23.34% | Mizuho | $66 → $65 | Maintains | Neutral | |||
04/11/2024 | 25.24% | Scotiabank | $58 → $66 | Maintains | Sector Outperform | |||
04/05/2024 | 32.83% | Piper Sandler | $67 → $70 | Maintains | Overweight | |||
03/22/2024 | 25.24% | Mizuho | $63 → $66 | Maintains | Neutral | |||
03/15/2024 | 48.01% | B of A Securities | $62 → $78 | Upgrade | Neutral → Buy | |||
03/08/2024 | 27.13% | Piper Sandler | $76 → $67 | Maintains | Overweight | |||
02/26/2024 | 13.85% | Barclays | → $60 | Reinstates | → Equal-Weight | |||
02/22/2024 | 27.13% | Wells Fargo | $64 → $67 | Maintains | Overweight | |||
02/14/2024 | 38.52% | UBS | $64 → $73 | Upgrade | Neutral → Buy | |||
12/04/2023 | 21.44% | UBS | $62 → $64 | Maintains | Neutral | |||
10/17/2023 | 23.34% | Morgan Stanley | $70 → $65 | Maintains | Overweight | |||
10/09/2023 | 23.34% | Piper Sandler | $73 → $65 | Maintains | Overweight | |||
10/06/2023 | 21.44% | Mizuho | $72 → $64 | Maintains | Neutral | |||
10/05/2023 | 15.75% | JP Morgan | $62 → $61 | Maintains | Neutral | |||
10/05/2023 | 23.34% | BMO Capital | → $65 | Initiates | → Outperform | |||
09/18/2023 | 32.83% | B of A Securities | $65 → $70 | Maintains | Neutral | |||
09/18/2023 | 36.62% | Mizuho | $63 → $72 | Maintains | Neutral | |||
09/08/2023 | 29.03% | Wells Fargo | $60 → $68 | Maintains | Overweight | |||
08/16/2023 | — | Mizuho | — | Downgrade | Buy → Neutral | |||
08/15/2023 | 23.34% | B of A Securities | $62 → $65 | Downgrade | Buy → Neutral | |||
08/09/2023 | 19.54% | Goldman Sachs | $56 → $63 | Maintains | Buy | |||
08/08/2023 | 19.54% | Goldman Sachs | $56 → $63 | Maintains | Buy | |||
08/07/2023 | 10.06% | UBS | $53 → $58 | Maintains | Neutral | |||
08/04/2023 | 13.85% | Wells Fargo | $52 → $60 | Maintains | Overweight | |||
07/19/2023 | 32.83% | Morgan Stanley | $70 → $70 | Reiterates | Overweight → Overweight | |||
07/13/2023 | 19.54% | Piper Sandler | $57 → $63 | Maintains | Overweight | |||
07/10/2023 | -1.33% | Wells Fargo | $48 → $52 | Maintains | Overweight | |||
05/19/2023 | 6.26% | Mizuho | $69 → $56 | Maintains | Buy | |||
05/18/2023 | 30.93% | Piper Sandler | $73 → $69 | Maintains | Overweight | |||
05/08/2023 | -8.92% | Wells Fargo | $52 → $48 | Maintains | Overweight | |||
04/20/2023 | 38.52% | Piper Sandler | $73 → $73 | Maintains | Overweight | |||
04/18/2023 | -1.33% | Wells Fargo | $55 → $52 | Maintains | Overweight | |||
04/05/2023 | 38.52% | Piper Sandler | → $73 | Maintains | Overweight | |||
03/28/2023 | 10.06% | JP Morgan | $55 → $58 | Maintains | Neutral | |||
03/16/2023 | 4.36% | Wells Fargo | → $55 | Upgrade | Equal-Weight → Overweight |
PREGUNTAS FRECUENTES
¿Cuál es el precio objetivo de las acciones de HF Sinclair (DINO)?
El último precio objetivo de HF Sinclair (NYSE:DINO) fue comunicado por Piper Sandler el noviembre 14, 2025. La firma de analistas fijó un precio objetivo para $64.00 que espera DINO a rise dentro de 12 meses (un posible 20.50% upside). 39 firmas de analistas han reportado calificaciones en el último año.
¿Cuál es la calificación más reciente de los analistas sobre HF Sinclair (DINO)?
La última calificación de analistas para HF Sinclair (NYSE:DINO) fue proporcionada por Piper Sandler, y HF Sinclair mantuvo su neutral calificación.
¿Cuándo se produjo la última revisión al alza de HF Sinclair (DINO)?
La última revisión al alza de HF Sinclair Corp se produjo en mayo 13, 2025, cuando Mizuho elevó su precio objetivo a $47. Mizuho anteriormente tenía a neutral para HF Sinclair Corp.
¿Cuándo fue la última revisión a la baja de HF Sinclair (DINO)?
La última revisión a la baja de HF Sinclair Corp se produjo en julio 22, 2025, cuando Piper Sandler cambió su precio objetivo de $53 a $51 para HF Sinclair Corp.
¿Cuándo se publicará o actualizará la próxima calificación de los analistas para HF Sinclair (DINO)?
Los analistas llegan a las calificaciones de acciones después de hacer una investigación exhaustiva, que incluye revisar los estados financieros públicos, hablar con ejecutivos y clientes de HF Sinclair, y escuchar las teleconferencias de ganancias. La mayoría de los analistas hacen esto cada tres meses, por lo que deberías recibir 4 calificaciones por empresa al año. La última calificación de HF Sinclair se registró el noviembre 14, 2025, por lo que la próxima calificación estará disponible en torno al noviembre 14, 2026.
¿Es correcta la calificación de los analistas sobre HF Sinclair (DINO)?
Aunque las calificaciones son subjetivas y pueden cambiar, la última calificación de HF Sinclair (DINO) fue un mantuvo con un precio objetivo de $59.00 a $64.00. El precio actual al que cotiza HF Sinclair (DINO) es de $53.11, que es out of del rango previsto por el analista.
Explora calificaciones de analistas y precios objetivo sobre todos los valores.